Trial Profile

The Chinese University of Hong Kong Early Arthritis Study.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 29 Feb 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Infliximab (Primary) ; Methotrexate
Indications Atherosclerosis; Rheumatoid arthritis
Focus Therapeutic Use
Acronyms ERA

Most Recent Events

15 Sep 2012 Results published in The Journal of Rheumatology.
09 Nov 2011 Results assessing the effect of treatment on arterial stiffness presented at the 75th Annual Scientific Meeting of the American College of Rheumatology and the 46th Annual Meeting of the Association of Rheumatology and Health Professionals.
27 May 2010 Planned end date changed from Sep 2010 to Dec 2011 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com